March 2023

Modsim pharma and Pharmacelera announce a partnership on providing an extended portfolio of in-silico services

Barcelona and Uppsala, March 2nd, 2023 – Pharmacelera, the leading provider of computational tools for hit discovery, and MODSIM Pharma AB, the leading provider of physics-based biomolecular simulations tools, have announced a technology and business partnership to jointly provide an efficient in-silico platform from Hit… Read More »Modsim pharma and Pharmacelera announce a partnership on providing an extended portfolio of in-silico services